Wdowiak Kamil, Tajber Lidia, Miklaszewski Andrzej, Cielecka-Piontek Judyta
Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, 3 Rokietnicka St., 60-806 Poznan, Poland.
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, University of Dublin, D02 PN40 Dublin, Ireland.
Pharmaceutics. 2024 Dec 27;17(1):26. doi: 10.3390/pharmaceutics17010026.
Curcumin and hesperetin are plant polyphenols known for their poor solubility. To address this limitation, we prepared amorphous PVP K30-phosphatidylcholine dispersions via hot-melt extrusion. This study aimed to evaluate the effects of the amounts of active ingredients and phosphatidylcholine, as well as the process temperature, on the performance of the dispersions. A Box-Behnken design was employed to assess these factors. Solid-state characterization and biopharmaceutical studies were then conducted. X-ray powder diffraction (XRPD) was used to confirm the amorphous nature of the dispersions, while differential scanning calorimetry (DSC) provided insight into the miscibility of the systems. Fourier-transform infrared spectroscopy (FTIR) was employed to assess the intermolecular interactions. The apparent solubility and dissolution profiles of the systems were studied in phosphate buffer at pH 6.8. In vitro permeability across the gastrointestinal tract and blood-brain barrier was evaluated using the parallel artificial membrane permeability assay. The quantities of polyphenols and phospholipids were identified as significant factors influencing the biopharmaceutical performance of the systems. Solid-state analysis confirmed the formation of amorphous dispersions and the development of interactions among components. Notably, a significant improvement in solubility was observed, with formulations exhibiting distinct release patterns for the active compounds. Furthermore, the in vitro permeability through the gastrointestinal tract and blood-brain barrier was enhanced. The findings suggest that amorphous PVP K30-phosphatidylcholine dispersions have the potential to improve the biopharmaceutical properties of curcumin and hesperetin.
姜黄素和橙皮素是已知溶解度较差的植物多酚。为了解决这一局限性,我们通过热熔挤出制备了无定形聚维酮K30 - 磷脂酰胆碱分散体。本研究旨在评估活性成分和磷脂酰胆碱的用量以及加工温度对分散体性能的影响。采用Box - Behnken设计来评估这些因素。然后进行了固态表征和生物药剂学研究。利用X射线粉末衍射(XRPD)来确认分散体的无定形性质,而差示扫描量热法(DSC)则深入了解体系的混溶性。采用傅里叶变换红外光谱(FTIR)来评估分子间相互作用。在pH 6.8的磷酸盐缓冲液中研究了该体系的表观溶解度和溶出曲线。使用平行人工膜通透性试验评估了其在胃肠道和血脑屏障的体外通透性。多酚和磷脂的量被确定为影响该体系生物药剂学性能的重要因素。固态分析证实了无定形分散体的形成以及各组分间相互作用的发展。值得注意的是,观察到溶解度有显著提高,制剂对活性化合物呈现出不同的释放模式。此外,其在胃肠道和血脑屏障的体外通透性也得到了增强。研究结果表明,无定形聚维酮K30 - 磷脂酰胆碱分散体有潜力改善姜黄素和橙皮素的生物药剂学性质。